Stellantis NV
NYSE:STLA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.53
14.21
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
STLA
stock under the Base Case scenario is
27.37
USD.
Compared to the current market price of 12.05 USD,
Stellantis NV
is
Undervalued by 56%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Stellantis NV.
| US |
|
Tesla Inc
NASDAQ:TSLA
|
|
| JP |
|
Toyota Motor Corp
TSE:7203
|
|
| CN |
|
BYD Co Ltd
SZSE:002594
|
|
| DE |
|
Mercedes Benz Group AG
MIL:MBG
|
|
| IT |
|
Ferrari NV
MIL:RACE
|
|
| DE |
|
Daimler AG
XETRA:DAI
|
|
| US |
|
General Motors Co
NYSE:GM
|
|
| DE |
|
Bayerische Motoren Werke AG
XETRA:BMW
|
|
| DE |
|
Mercedes-Benz Group AG
XETRA:MBG
|
|
| DE |
V
|
Volkswagen AG
XETRA:VOW
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Stellantis NV
Balance Sheet Decomposition
Stellantis NV
| Current Assets | 80.5B |
| Cash & Short-Term Investments | 32.7B |
| Receivables | 20.8B |
| Other Current Assets | 27B |
| Non-Current Assets | 120.2B |
| Long-Term Investments | 10.3B |
| PP&E | 44.9B |
| Intangibles | 49.8B |
| Other Non-Current Assets | 15.2B |
| Current Liabilities | 75.9B |
| Accounts Payable | 29.9B |
| Accrued Liabilities | 10.4B |
| Other Current Liabilities | 35.6B |
| Non-Current Liabilities | 51.7B |
| Long-Term Debt | 27.5B |
| Other Non-Current Liabilities | 24.1B |
Free Cash Flow Analysis
Stellantis NV
| EUR | |
| Free Cash Flow | EUR |
Earnings Waterfall
Stellantis NV
|
Revenue
|
146.1B
EUR
|
|
Cost of Revenue
|
-134.8B
EUR
|
|
Gross Profit
|
11.3B
EUR
|
|
Operating Expenses
|
-13.9B
EUR
|
|
Operating Income
|
-2.6B
EUR
|
|
Other Expenses
|
167m
EUR
|
|
Net Income
|
-2.4B
EUR
|
STLA Profitability Score
Profitability Due Diligence
Stellantis NV's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
Score
Stellantis NV's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
STLA Solvency Score
Solvency Due Diligence
Stellantis NV's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Stellantis NV's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
STLA Price Targets Summary
Stellantis NV
According to Wall Street analysts, the average 1-year price target for
STLA
is 11.37 USD
with a low forecast of 7.05 USD and a high forecast of 15.26 USD.
Dividends
Current shareholder yield for
STLAM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
STLA
stock under the Base Case scenario is
27.37
USD.
Compared to the current market price of 12.05 USD,
Stellantis NV
is
Undervalued by 56%.